(19)
(11)EP 1 278 877 A1

(12)

(43)Date of publication:
29.01.2003 Bulletin 2003/05

(21)Application number: 01966769.0

(22)Date of filing:  12.04.2001
(51)International Patent Classification (IPC)7C12N 15/79, C12N 15/67, C12N 9/50, A61K 31/70
(86)International application number:
PCT/GB0101/664
(87)International publication number:
WO 0107/7349 (18.10.2001 Gazette  2001/42)
(84)Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30)Priority: 12.04.2000 GB 0008903

(71)Applicant: University Court of The University of Glasgow
Glasgow G12 8QQ (GB)

(72)Inventors:
  • Mottram, Jeremy C.Wellcome Ctr for Mol. Parasit
    G11 6NU (GB)
  • Coombs, Graham H.Infection & Immunity
    Glasgow G12 8QQ (GB)
  • Denise, HubertWellcome Ctr for Mol. Parasitology
    Glasgow G11 6NU (GB)
  • Brooks, Darren R.Peptide Metabolism Group
    Leeds LS2 9JT (GB)

(74)Representative: Chapman, Paul Gilmour et al
Cruikshank & Fairweather,19 Royal Exchange Square
Glasgow G1 3AE
Glasgow G1 3AE (GB)

  


(54)USE OF 3'-UTR'S FROM CYSTEINE PROTEINASE GENES CPB2 AND CPB2.8 OF LEISHMANIA FOR DIRECTING STAGE-SPECIFIC EXPRESSION